Google lands deal with Stanford, putting its cloud tech at the heart of genomics drive

Google building

Stanford Medicine has picked Google Genomics to power its healthcare data science drive. The deal sees Stanford make the Alphabet ($GOOG) subsidiary’s cloud platform the backbone of its Clinical Genomics Service, an offering the heavyweight medical school sees propelling its research and patient care units forward.

When Stanford’s Clinical Genomics Service goes live later this year, it will mark a step forward in the medical school’s attempts to incorporate genetic testing into routine healthcare. Stanford will store data generated in these tests on Google’s platform, which, as with all cloud-based systems, offers an easily scalable, remotely accessible way of housing information. This is important for Stanford. The medical school aspires to sequence thousands of genomes.

“We want to be seen as leaders in determining how genomic data, when combined with other data, is able to predict when we're more prone to developing the disease,” Lloyd Minor, dean of Stanford Medicine, told Fast Company.

Infographic Download

Reducing Time to Clinic for Your Biomedical Applications

Gelatin methacryloyl (GelMA)-based biomaterials have been widely used in various biomedical research applications due to their suitable biological properties and tunable physical characteristics. Especially over the past 5 years, GelMA-oriented research and patent applications have been growing exponentially, and many of these research concepts are now being translated towards the clinic. Suitable GelMA biomaterials are therefore indispensable to keep pace with the newest medical innovations.

Download to learn more about the benefits of GelMA in various biomedical applications and how X-Pure® GelMA can help you in your developments.

Landing Stanford, a high-profile organization with potentially substantial data storage and analysis needs, represents a boost for Google Genomics. The search giant set up the offering in 2014. Users of the service can store a 30x human whole genome sequence in the cloud for $25 a year. Google then charges extra to perform computations on the data.

The service pits Google against some familiar competitors, notably Amazon ($AMZN) and Microsoft ($MSFT). Google beat its rivals to the Stanford deal, in part because it is a long-standing collaborator of the medical school. To consistently land contracts with organizations it lacks existing relationships with, Google will have find ways to differentiate its service. This is tricky.

Pricing is already competitive, leaving the cloud providers with limited opportunities to compete on cost. Similarly, with Amazon typically topping lists of the most reliable cloud services--and leaving its competitors with little scope to best its performance--Google and Microsoft are unlikely to capture market share on the basis of uptime.

The Stanford deal shows one way Google is looking to gain an edge: machine learning. Stanford plans to work with Google to assess ways in which the technology can advance its research and patient care agendas.

- read the release
- and Fast Company’s piece

Related Articles:
Google to pair its cloud-computing power with Broad's analytic tools
Amazon, Google duke it out for control of cloud genomics

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.